Delivery Order SPE2DB22D1017-SPE2DB25FG5FP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,071.88 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in 30-tablet units. This contract, awarded on June 4, 2025, with completion targeted for June 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively issued and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,667.30 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, for the supply of Mestinon 180 mg Timespan in units of 30 tablets. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025....
- The Defense Logistics Agency awarded a $9,466.34 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $35,530.01 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a direct procurement of pharmaceutical products to support military and federal healthcare operations. The contract was competitively awarded with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a $5,900.40 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.36 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mestinon is a pharmaceutical product used in the treatment of myasthenia gravis and related...
- The Defense Logistics Agency awarded a $10.87K delivery order to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan tablets (30-count units) under a firm fixed-price contract structure. The award, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $3,382.75 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,496.72 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,095.12 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order was placed on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG5FPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,553.90 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price contract, awarded on June 17, 2025, with an ultimate completion date of June 18, 2025, represents a competitively awarded non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 vehicle running through December 2026 that enables pharmaceutical supply across military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical needs through open competition, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Mestinon—a medication used to treat myasthenia gravis—exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems through flexible and reliable pharmaceutical supply arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 6/17/25 |